Global Oral Live Cholera Vaccines Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Oral Live Cholera Vaccines market size was valued at US$ 83 million in 2023. With growing demand in downstream market, the Oral Live Cholera Vaccines is forecast to a readjusted size of US$ 135.7 million by 2030 with a CAGR of 7.3% during review period.
The research report highlights the growth potential of the global Oral Live Cholera Vaccines market. Oral Live Cholera Vaccines are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Oral Live Cholera Vaccines. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Oral Live Cholera Vaccines market.
Live, orally administered, attenuated vaccine strains of Vibrio cholerae have many theoretical advantages over killed vaccines.
Factors such as increasing incidence of cholera outbreaks, rising awareness about the disease and its prevention, and government initiatives to control cholera are driving market growth. Oral live cholera vaccines offer advantages such as ease of administration, cost-effectiveness, and potential for herd immunity. The market is characterized by the presence of both established pharmaceutical companies and emerging players. However, challenges such as vaccine storage and distribution requirements, limited accessibility in resource-constrained regions, and the need for cold chain maintenance may pose obstacles to market expansion.
Key Features:
The report on Oral Live Cholera Vaccines market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Oral Live Cholera Vaccines market. It may include historical data, market segmentation by Type (e.g., Euvichol- Plus, DUKORAL), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Oral Live Cholera Vaccines market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Oral Live Cholera Vaccines market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Oral Live Cholera Vaccines industry. This include advancements in Oral Live Cholera Vaccines technology, Oral Live Cholera Vaccines new entrants, Oral Live Cholera Vaccines new investment, and other innovations that are shaping the future of Oral Live Cholera Vaccines.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Oral Live Cholera Vaccines market. It includes factors influencing customer ' purchasing decisions, preferences for Oral Live Cholera Vaccines product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Oral Live Cholera Vaccines market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Oral Live Cholera Vaccines market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Oral Live Cholera Vaccines market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Oral Live Cholera Vaccines industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Oral Live Cholera Vaccines market.
Market Segmentation:
Oral Live Cholera Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Oral Live Cholera Vaccines market?
What factors are driving Oral Live Cholera Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oral Live Cholera Vaccines market opportunities vary by end market size?
How does Oral Live Cholera Vaccines break out type, application?
According to our LPI (LP Information) latest study, the global Oral Live Cholera Vaccines market size was valued at US$ 83 million in 2023. With growing demand in downstream market, the Oral Live Cholera Vaccines is forecast to a readjusted size of US$ 135.7 million by 2030 with a CAGR of 7.3% during review period.
The research report highlights the growth potential of the global Oral Live Cholera Vaccines market. Oral Live Cholera Vaccines are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Oral Live Cholera Vaccines. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Oral Live Cholera Vaccines market.
Live, orally administered, attenuated vaccine strains of Vibrio cholerae have many theoretical advantages over killed vaccines.
Factors such as increasing incidence of cholera outbreaks, rising awareness about the disease and its prevention, and government initiatives to control cholera are driving market growth. Oral live cholera vaccines offer advantages such as ease of administration, cost-effectiveness, and potential for herd immunity. The market is characterized by the presence of both established pharmaceutical companies and emerging players. However, challenges such as vaccine storage and distribution requirements, limited accessibility in resource-constrained regions, and the need for cold chain maintenance may pose obstacles to market expansion.
Key Features:
The report on Oral Live Cholera Vaccines market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Oral Live Cholera Vaccines market. It may include historical data, market segmentation by Type (e.g., Euvichol- Plus, DUKORAL), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Oral Live Cholera Vaccines market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Oral Live Cholera Vaccines market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Oral Live Cholera Vaccines industry. This include advancements in Oral Live Cholera Vaccines technology, Oral Live Cholera Vaccines new entrants, Oral Live Cholera Vaccines new investment, and other innovations that are shaping the future of Oral Live Cholera Vaccines.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Oral Live Cholera Vaccines market. It includes factors influencing customer ' purchasing decisions, preferences for Oral Live Cholera Vaccines product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Oral Live Cholera Vaccines market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Oral Live Cholera Vaccines market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Oral Live Cholera Vaccines market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Oral Live Cholera Vaccines industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Oral Live Cholera Vaccines market.
Market Segmentation:
Oral Live Cholera Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Euvichol- Plus
- DUKORAL
- Shanchol
- Others
- Prevention
- Emergency Response
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- PaxVax
- Sanofi
- Valneva
- EuBiologics
- Shanghai United Cell Biotechnology
- Vabiotech
What is the 10-year outlook for the global Oral Live Cholera Vaccines market?
What factors are driving Oral Live Cholera Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oral Live Cholera Vaccines market opportunities vary by end market size?
How does Oral Live Cholera Vaccines break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oral Live Cholera Vaccines Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Oral Live Cholera Vaccines by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Oral Live Cholera Vaccines by Country/Region, 2019, 2023 & 2030
2.2 Oral Live Cholera Vaccines Segment by Type
2.2.1 Euvichol- Plus
2.2.2 DUKORAL
2.2.3 Shanchol
2.2.4 Others
2.3 Oral Live Cholera Vaccines Sales by Type
2.3.1 Global Oral Live Cholera Vaccines Sales Market Share by Type (2019-2024)
2.3.2 Global Oral Live Cholera Vaccines Revenue and Market Share by Type (2019-2024)
2.3.3 Global Oral Live Cholera Vaccines Sale Price by Type (2019-2024)
2.4 Oral Live Cholera Vaccines Segment by Application
2.4.1 Prevention
2.4.2 Emergency Response
2.5 Oral Live Cholera Vaccines Sales by Application
2.5.1 Global Oral Live Cholera Vaccines Sale Market Share by Application (2019-2024)
2.5.2 Global Oral Live Cholera Vaccines Revenue and Market Share by Application (2019-2024)
2.5.3 Global Oral Live Cholera Vaccines Sale Price by Application (2019-2024)
3 GLOBAL ORAL LIVE CHOLERA VACCINES BY COMPANY
3.1 Global Oral Live Cholera Vaccines Breakdown Data by Company
3.1.1 Global Oral Live Cholera Vaccines Annual Sales by Company (2019-2024)
3.1.2 Global Oral Live Cholera Vaccines Sales Market Share by Company (2019-2024)
3.2 Global Oral Live Cholera Vaccines Annual Revenue by Company (2019-2024)
3.2.1 Global Oral Live Cholera Vaccines Revenue by Company (2019-2024)
3.2.2 Global Oral Live Cholera Vaccines Revenue Market Share by Company (2019-2024)
3.3 Global Oral Live Cholera Vaccines Sale Price by Company
3.4 Key Manufacturers Oral Live Cholera Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Live Cholera Vaccines Product Location Distribution
3.4.2 Players Oral Live Cholera Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ORAL LIVE CHOLERA VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Oral Live Cholera Vaccines Market Size by Geographic Region (2019-2024)
4.1.1 Global Oral Live Cholera Vaccines Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Oral Live Cholera Vaccines Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Oral Live Cholera Vaccines Market Size by Country/Region (2019-2024)
4.2.1 Global Oral Live Cholera Vaccines Annual Sales by Country/Region (2019-2024)
4.2.2 Global Oral Live Cholera Vaccines Annual Revenue by Country/Region (2019-2024)
4.3 Americas Oral Live Cholera Vaccines Sales Growth
4.4 APAC Oral Live Cholera Vaccines Sales Growth
4.5 Europe Oral Live Cholera Vaccines Sales Growth
4.6 Middle East & Africa Oral Live Cholera Vaccines Sales Growth
5 AMERICAS
5.1 Americas Oral Live Cholera Vaccines Sales by Country
5.1.1 Americas Oral Live Cholera Vaccines Sales by Country (2019-2024)
5.1.2 Americas Oral Live Cholera Vaccines Revenue by Country (2019-2024)
5.2 Americas Oral Live Cholera Vaccines Sales by Type
5.3 Americas Oral Live Cholera Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Live Cholera Vaccines Sales by Region
6.1.1 APAC Oral Live Cholera Vaccines Sales by Region (2019-2024)
6.1.2 APAC Oral Live Cholera Vaccines Revenue by Region (2019-2024)
6.2 APAC Oral Live Cholera Vaccines Sales by Type
6.3 APAC Oral Live Cholera Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oral Live Cholera Vaccines by Country
7.1.1 Europe Oral Live Cholera Vaccines Sales by Country (2019-2024)
7.1.2 Europe Oral Live Cholera Vaccines Revenue by Country (2019-2024)
7.2 Europe Oral Live Cholera Vaccines Sales by Type
7.3 Europe Oral Live Cholera Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oral Live Cholera Vaccines by Country
8.1.1 Middle East & Africa Oral Live Cholera Vaccines Sales by Country (2019-2024)
8.1.2 Middle East & Africa Oral Live Cholera Vaccines Revenue by Country (2019-2024)
8.2 Middle East & Africa Oral Live Cholera Vaccines Sales by Type
8.3 Middle East & Africa Oral Live Cholera Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Live Cholera Vaccines
10.3 Manufacturing Process Analysis of Oral Live Cholera Vaccines
10.4 Industry Chain Structure of Oral Live Cholera Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Live Cholera Vaccines Distributors
11.3 Oral Live Cholera Vaccines Customer
12 WORLD FORECAST REVIEW FOR ORAL LIVE CHOLERA VACCINES BY GEOGRAPHIC REGION
12.1 Global Oral Live Cholera Vaccines Market Size Forecast by Region
12.1.1 Global Oral Live Cholera Vaccines Forecast by Region (2025-2030)
12.1.2 Global Oral Live Cholera Vaccines Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oral Live Cholera Vaccines Forecast by Type
12.7 Global Oral Live Cholera Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 PaxVax
13.1.1 PaxVax Company Information
13.1.2 PaxVax Oral Live Cholera Vaccines Product Portfolios and Specifications
13.1.3 PaxVax Oral Live Cholera Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 PaxVax Main Business Overview
13.1.5 PaxVax Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Oral Live Cholera Vaccines Product Portfolios and Specifications
13.2.3 Sanofi Oral Live Cholera Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Valneva
13.3.1 Valneva Company Information
13.3.2 Valneva Oral Live Cholera Vaccines Product Portfolios and Specifications
13.3.3 Valneva Oral Live Cholera Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Valneva Main Business Overview
13.3.5 Valneva Latest Developments
13.4 EuBiologics
13.4.1 EuBiologics Company Information
13.4.2 EuBiologics Oral Live Cholera Vaccines Product Portfolios and Specifications
13.4.3 EuBiologics Oral Live Cholera Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 EuBiologics Main Business Overview
13.4.5 EuBiologics Latest Developments
13.5 Shanghai United Cell Biotechnology
13.5.1 Shanghai United Cell Biotechnology Company Information
13.5.2 Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Product Portfolios and Specifications
13.5.3 Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Shanghai United Cell Biotechnology Main Business Overview
13.5.5 Shanghai United Cell Biotechnology Latest Developments
13.6 Vabiotech
13.6.1 Vabiotech Company Information
13.6.2 Vabiotech Oral Live Cholera Vaccines Product Portfolios and Specifications
13.6.3 Vabiotech Oral Live Cholera Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Vabiotech Main Business Overview
13.6.5 Vabiotech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oral Live Cholera Vaccines Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Oral Live Cholera Vaccines by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Oral Live Cholera Vaccines by Country/Region, 2019, 2023 & 2030
2.2 Oral Live Cholera Vaccines Segment by Type
2.2.1 Euvichol- Plus
2.2.2 DUKORAL
2.2.3 Shanchol
2.2.4 Others
2.3 Oral Live Cholera Vaccines Sales by Type
2.3.1 Global Oral Live Cholera Vaccines Sales Market Share by Type (2019-2024)
2.3.2 Global Oral Live Cholera Vaccines Revenue and Market Share by Type (2019-2024)
2.3.3 Global Oral Live Cholera Vaccines Sale Price by Type (2019-2024)
2.4 Oral Live Cholera Vaccines Segment by Application
2.4.1 Prevention
2.4.2 Emergency Response
2.5 Oral Live Cholera Vaccines Sales by Application
2.5.1 Global Oral Live Cholera Vaccines Sale Market Share by Application (2019-2024)
2.5.2 Global Oral Live Cholera Vaccines Revenue and Market Share by Application (2019-2024)
2.5.3 Global Oral Live Cholera Vaccines Sale Price by Application (2019-2024)
3 GLOBAL ORAL LIVE CHOLERA VACCINES BY COMPANY
3.1 Global Oral Live Cholera Vaccines Breakdown Data by Company
3.1.1 Global Oral Live Cholera Vaccines Annual Sales by Company (2019-2024)
3.1.2 Global Oral Live Cholera Vaccines Sales Market Share by Company (2019-2024)
3.2 Global Oral Live Cholera Vaccines Annual Revenue by Company (2019-2024)
3.2.1 Global Oral Live Cholera Vaccines Revenue by Company (2019-2024)
3.2.2 Global Oral Live Cholera Vaccines Revenue Market Share by Company (2019-2024)
3.3 Global Oral Live Cholera Vaccines Sale Price by Company
3.4 Key Manufacturers Oral Live Cholera Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Live Cholera Vaccines Product Location Distribution
3.4.2 Players Oral Live Cholera Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ORAL LIVE CHOLERA VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Oral Live Cholera Vaccines Market Size by Geographic Region (2019-2024)
4.1.1 Global Oral Live Cholera Vaccines Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Oral Live Cholera Vaccines Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Oral Live Cholera Vaccines Market Size by Country/Region (2019-2024)
4.2.1 Global Oral Live Cholera Vaccines Annual Sales by Country/Region (2019-2024)
4.2.2 Global Oral Live Cholera Vaccines Annual Revenue by Country/Region (2019-2024)
4.3 Americas Oral Live Cholera Vaccines Sales Growth
4.4 APAC Oral Live Cholera Vaccines Sales Growth
4.5 Europe Oral Live Cholera Vaccines Sales Growth
4.6 Middle East & Africa Oral Live Cholera Vaccines Sales Growth
5 AMERICAS
5.1 Americas Oral Live Cholera Vaccines Sales by Country
5.1.1 Americas Oral Live Cholera Vaccines Sales by Country (2019-2024)
5.1.2 Americas Oral Live Cholera Vaccines Revenue by Country (2019-2024)
5.2 Americas Oral Live Cholera Vaccines Sales by Type
5.3 Americas Oral Live Cholera Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Live Cholera Vaccines Sales by Region
6.1.1 APAC Oral Live Cholera Vaccines Sales by Region (2019-2024)
6.1.2 APAC Oral Live Cholera Vaccines Revenue by Region (2019-2024)
6.2 APAC Oral Live Cholera Vaccines Sales by Type
6.3 APAC Oral Live Cholera Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oral Live Cholera Vaccines by Country
7.1.1 Europe Oral Live Cholera Vaccines Sales by Country (2019-2024)
7.1.2 Europe Oral Live Cholera Vaccines Revenue by Country (2019-2024)
7.2 Europe Oral Live Cholera Vaccines Sales by Type
7.3 Europe Oral Live Cholera Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oral Live Cholera Vaccines by Country
8.1.1 Middle East & Africa Oral Live Cholera Vaccines Sales by Country (2019-2024)
8.1.2 Middle East & Africa Oral Live Cholera Vaccines Revenue by Country (2019-2024)
8.2 Middle East & Africa Oral Live Cholera Vaccines Sales by Type
8.3 Middle East & Africa Oral Live Cholera Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Live Cholera Vaccines
10.3 Manufacturing Process Analysis of Oral Live Cholera Vaccines
10.4 Industry Chain Structure of Oral Live Cholera Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Live Cholera Vaccines Distributors
11.3 Oral Live Cholera Vaccines Customer
12 WORLD FORECAST REVIEW FOR ORAL LIVE CHOLERA VACCINES BY GEOGRAPHIC REGION
12.1 Global Oral Live Cholera Vaccines Market Size Forecast by Region
12.1.1 Global Oral Live Cholera Vaccines Forecast by Region (2025-2030)
12.1.2 Global Oral Live Cholera Vaccines Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oral Live Cholera Vaccines Forecast by Type
12.7 Global Oral Live Cholera Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 PaxVax
13.1.1 PaxVax Company Information
13.1.2 PaxVax Oral Live Cholera Vaccines Product Portfolios and Specifications
13.1.3 PaxVax Oral Live Cholera Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 PaxVax Main Business Overview
13.1.5 PaxVax Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Oral Live Cholera Vaccines Product Portfolios and Specifications
13.2.3 Sanofi Oral Live Cholera Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Valneva
13.3.1 Valneva Company Information
13.3.2 Valneva Oral Live Cholera Vaccines Product Portfolios and Specifications
13.3.3 Valneva Oral Live Cholera Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Valneva Main Business Overview
13.3.5 Valneva Latest Developments
13.4 EuBiologics
13.4.1 EuBiologics Company Information
13.4.2 EuBiologics Oral Live Cholera Vaccines Product Portfolios and Specifications
13.4.3 EuBiologics Oral Live Cholera Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 EuBiologics Main Business Overview
13.4.5 EuBiologics Latest Developments
13.5 Shanghai United Cell Biotechnology
13.5.1 Shanghai United Cell Biotechnology Company Information
13.5.2 Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Product Portfolios and Specifications
13.5.3 Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Shanghai United Cell Biotechnology Main Business Overview
13.5.5 Shanghai United Cell Biotechnology Latest Developments
13.6 Vabiotech
13.6.1 Vabiotech Company Information
13.6.2 Vabiotech Oral Live Cholera Vaccines Product Portfolios and Specifications
13.6.3 Vabiotech Oral Live Cholera Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Vabiotech Main Business Overview
13.6.5 Vabiotech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Oral Live Cholera Vaccines Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Oral Live Cholera Vaccines Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Euvichol- Plus
Table 4. Major Players of DUKORAL
Table 5. Major Players of Shanchol
Table 6. Major Players of Others
Table 7. Global Oral Live Cholera Vaccines Sales by Type (2019-2024) & (K Units)
Table 8. Global Oral Live Cholera Vaccines Sales Market Share by Type (2019-2024)
Table 9. Global Oral Live Cholera Vaccines Revenue by Type (2019-2024) & ($ million)
Table 10. Global Oral Live Cholera Vaccines Revenue Market Share by Type (2019-2024)
Table 11. Global Oral Live Cholera Vaccines Sale Price by Type (2019-2024) & (USD/Unit)
Table 12. Global Oral Live Cholera Vaccines Sales by Application (2019-2024) & (K Units)
Table 13. Global Oral Live Cholera Vaccines Sales Market Share by Application (2019-2024)
Table 14. Global Oral Live Cholera Vaccines Revenue by Application (2019-2024)
Table 15. Global Oral Live Cholera Vaccines Revenue Market Share by Application (2019-2024)
Table 16. Global Oral Live Cholera Vaccines Sale Price by Application (2019-2024) & (USD/Unit)
Table 17. Global Oral Live Cholera Vaccines Sales by Company (2019-2024) & (K Units)
Table 18. Global Oral Live Cholera Vaccines Sales Market Share by Company (2019-2024)
Table 19. Global Oral Live Cholera Vaccines Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Oral Live Cholera Vaccines Revenue Market Share by Company (2019-2024)
Table 21. Global Oral Live Cholera Vaccines Sale Price by Company (2019-2024) & (USD/Unit)
Table 22. Key Manufacturers Oral Live Cholera Vaccines Producing Area Distribution and Sales Area
Table 23. Players Oral Live Cholera Vaccines Products Offered
Table 24. Oral Live Cholera Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Oral Live Cholera Vaccines Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Oral Live Cholera Vaccines Sales Market Share Geographic Region (2019-2024)
Table 29. Global Oral Live Cholera Vaccines Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Oral Live Cholera Vaccines Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Oral Live Cholera Vaccines Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Oral Live Cholera Vaccines Sales Market Share by Country/Region (2019-2024)
Table 33. Global Oral Live Cholera Vaccines Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Oral Live Cholera Vaccines Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Oral Live Cholera Vaccines Sales by Country (2019-2024) & (K Units)
Table 36. Americas Oral Live Cholera Vaccines Sales Market Share by Country (2019-2024)
Table 37. Americas Oral Live Cholera Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Oral Live Cholera Vaccines Revenue Market Share by Country (2019-2024)
Table 39. Americas Oral Live Cholera Vaccines Sales by Type (2019-2024) & (K Units)
Table 40. Americas Oral Live Cholera Vaccines Sales by Application (2019-2024) & (K Units)
Table 41. APAC Oral Live Cholera Vaccines Sales by Region (2019-2024) & (K Units)
Table 42. APAC Oral Live Cholera Vaccines Sales Market Share by Region (2019-2024)
Table 43. APAC Oral Live Cholera Vaccines Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Oral Live Cholera Vaccines Revenue Market Share by Region (2019-2024)
Table 45. APAC Oral Live Cholera Vaccines Sales by Type (2019-2024) & (K Units)
Table 46. APAC Oral Live Cholera Vaccines Sales by Application (2019-2024) & (K Units)
Table 47. Europe Oral Live Cholera Vaccines Sales by Country (2019-2024) & (K Units)
Table 48. Europe Oral Live Cholera Vaccines Sales Market Share by Country (2019-2024)
Table 49. Europe Oral Live Cholera Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Oral Live Cholera Vaccines Revenue Market Share by Country (2019-2024)
Table 51. Europe Oral Live Cholera Vaccines Sales by Type (2019-2024) & (K Units)
Table 52. Europe Oral Live Cholera Vaccines Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Oral Live Cholera Vaccines Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Oral Live Cholera Vaccines Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Oral Live Cholera Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Oral Live Cholera Vaccines Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Oral Live Cholera Vaccines Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Oral Live Cholera Vaccines Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Oral Live Cholera Vaccines
Table 60. Key Market Challenges & Risks of Oral Live Cholera Vaccines
Table 61. Key Industry Trends of Oral Live Cholera Vaccines
Table 62. Oral Live Cholera Vaccines Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Oral Live Cholera Vaccines Distributors List
Table 65. Oral Live Cholera Vaccines Customer List
Table 66. Global Oral Live Cholera Vaccines Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Oral Live Cholera Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Oral Live Cholera Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Oral Live Cholera Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Oral Live Cholera Vaccines Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Oral Live Cholera Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Oral Live Cholera Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Oral Live Cholera Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Oral Live Cholera Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Oral Live Cholera Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Oral Live Cholera Vaccines Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Oral Live Cholera Vaccines Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Oral Live Cholera Vaccines Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Oral Live Cholera Vaccines Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. PaxVax Basic Information, Oral Live Cholera Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 81. PaxVax Oral Live Cholera Vaccines Product Portfolios and Specifications
Table 82. PaxVax Oral Live Cholera Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. PaxVax Main Business
Table 84. PaxVax Latest Developments
Table 85. Sanofi Basic Information, Oral Live Cholera Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 86. Sanofi Oral Live Cholera Vaccines Product Portfolios and Specifications
Table 87. Sanofi Oral Live Cholera Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Sanofi Main Business
Table 89. Sanofi Latest Developments
Table 90. Valneva Basic Information, Oral Live Cholera Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 91. Valneva Oral Live Cholera Vaccines Product Portfolios and Specifications
Table 92. Valneva Oral Live Cholera Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Valneva Main Business
Table 94. Valneva Latest Developments
Table 95. EuBiologics Basic Information, Oral Live Cholera Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 96. EuBiologics Oral Live Cholera Vaccines Product Portfolios and Specifications
Table 97. EuBiologics Oral Live Cholera Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. EuBiologics Main Business
Table 99. EuBiologics Latest Developments
Table 100. Shanghai United Cell Biotechnology Basic Information, Oral Live Cholera Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 101. Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Product Portfolios and Specifications
Table 102. Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Shanghai United Cell Biotechnology Main Business
Table 104. Shanghai United Cell Biotechnology Latest Developments
Table 105. Vabiotech Basic Information, Oral Live Cholera Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 106. Vabiotech Oral Live Cholera Vaccines Product Portfolios and Specifications
Table 107. Vabiotech Oral Live Cholera Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Vabiotech Main Business
Table 109. Vabiotech Latest Developments
Table 1. Oral Live Cholera Vaccines Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Oral Live Cholera Vaccines Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Euvichol- Plus
Table 4. Major Players of DUKORAL
Table 5. Major Players of Shanchol
Table 6. Major Players of Others
Table 7. Global Oral Live Cholera Vaccines Sales by Type (2019-2024) & (K Units)
Table 8. Global Oral Live Cholera Vaccines Sales Market Share by Type (2019-2024)
Table 9. Global Oral Live Cholera Vaccines Revenue by Type (2019-2024) & ($ million)
Table 10. Global Oral Live Cholera Vaccines Revenue Market Share by Type (2019-2024)
Table 11. Global Oral Live Cholera Vaccines Sale Price by Type (2019-2024) & (USD/Unit)
Table 12. Global Oral Live Cholera Vaccines Sales by Application (2019-2024) & (K Units)
Table 13. Global Oral Live Cholera Vaccines Sales Market Share by Application (2019-2024)
Table 14. Global Oral Live Cholera Vaccines Revenue by Application (2019-2024)
Table 15. Global Oral Live Cholera Vaccines Revenue Market Share by Application (2019-2024)
Table 16. Global Oral Live Cholera Vaccines Sale Price by Application (2019-2024) & (USD/Unit)
Table 17. Global Oral Live Cholera Vaccines Sales by Company (2019-2024) & (K Units)
Table 18. Global Oral Live Cholera Vaccines Sales Market Share by Company (2019-2024)
Table 19. Global Oral Live Cholera Vaccines Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Oral Live Cholera Vaccines Revenue Market Share by Company (2019-2024)
Table 21. Global Oral Live Cholera Vaccines Sale Price by Company (2019-2024) & (USD/Unit)
Table 22. Key Manufacturers Oral Live Cholera Vaccines Producing Area Distribution and Sales Area
Table 23. Players Oral Live Cholera Vaccines Products Offered
Table 24. Oral Live Cholera Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Oral Live Cholera Vaccines Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Oral Live Cholera Vaccines Sales Market Share Geographic Region (2019-2024)
Table 29. Global Oral Live Cholera Vaccines Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Oral Live Cholera Vaccines Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Oral Live Cholera Vaccines Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Oral Live Cholera Vaccines Sales Market Share by Country/Region (2019-2024)
Table 33. Global Oral Live Cholera Vaccines Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Oral Live Cholera Vaccines Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Oral Live Cholera Vaccines Sales by Country (2019-2024) & (K Units)
Table 36. Americas Oral Live Cholera Vaccines Sales Market Share by Country (2019-2024)
Table 37. Americas Oral Live Cholera Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Oral Live Cholera Vaccines Revenue Market Share by Country (2019-2024)
Table 39. Americas Oral Live Cholera Vaccines Sales by Type (2019-2024) & (K Units)
Table 40. Americas Oral Live Cholera Vaccines Sales by Application (2019-2024) & (K Units)
Table 41. APAC Oral Live Cholera Vaccines Sales by Region (2019-2024) & (K Units)
Table 42. APAC Oral Live Cholera Vaccines Sales Market Share by Region (2019-2024)
Table 43. APAC Oral Live Cholera Vaccines Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Oral Live Cholera Vaccines Revenue Market Share by Region (2019-2024)
Table 45. APAC Oral Live Cholera Vaccines Sales by Type (2019-2024) & (K Units)
Table 46. APAC Oral Live Cholera Vaccines Sales by Application (2019-2024) & (K Units)
Table 47. Europe Oral Live Cholera Vaccines Sales by Country (2019-2024) & (K Units)
Table 48. Europe Oral Live Cholera Vaccines Sales Market Share by Country (2019-2024)
Table 49. Europe Oral Live Cholera Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Oral Live Cholera Vaccines Revenue Market Share by Country (2019-2024)
Table 51. Europe Oral Live Cholera Vaccines Sales by Type (2019-2024) & (K Units)
Table 52. Europe Oral Live Cholera Vaccines Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Oral Live Cholera Vaccines Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Oral Live Cholera Vaccines Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Oral Live Cholera Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Oral Live Cholera Vaccines Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Oral Live Cholera Vaccines Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Oral Live Cholera Vaccines Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Oral Live Cholera Vaccines
Table 60. Key Market Challenges & Risks of Oral Live Cholera Vaccines
Table 61. Key Industry Trends of Oral Live Cholera Vaccines
Table 62. Oral Live Cholera Vaccines Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Oral Live Cholera Vaccines Distributors List
Table 65. Oral Live Cholera Vaccines Customer List
Table 66. Global Oral Live Cholera Vaccines Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Oral Live Cholera Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Oral Live Cholera Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Oral Live Cholera Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Oral Live Cholera Vaccines Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Oral Live Cholera Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Oral Live Cholera Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Oral Live Cholera Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Oral Live Cholera Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Oral Live Cholera Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Oral Live Cholera Vaccines Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Oral Live Cholera Vaccines Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Oral Live Cholera Vaccines Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Oral Live Cholera Vaccines Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. PaxVax Basic Information, Oral Live Cholera Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 81. PaxVax Oral Live Cholera Vaccines Product Portfolios and Specifications
Table 82. PaxVax Oral Live Cholera Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. PaxVax Main Business
Table 84. PaxVax Latest Developments
Table 85. Sanofi Basic Information, Oral Live Cholera Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 86. Sanofi Oral Live Cholera Vaccines Product Portfolios and Specifications
Table 87. Sanofi Oral Live Cholera Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Sanofi Main Business
Table 89. Sanofi Latest Developments
Table 90. Valneva Basic Information, Oral Live Cholera Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 91. Valneva Oral Live Cholera Vaccines Product Portfolios and Specifications
Table 92. Valneva Oral Live Cholera Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Valneva Main Business
Table 94. Valneva Latest Developments
Table 95. EuBiologics Basic Information, Oral Live Cholera Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 96. EuBiologics Oral Live Cholera Vaccines Product Portfolios and Specifications
Table 97. EuBiologics Oral Live Cholera Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. EuBiologics Main Business
Table 99. EuBiologics Latest Developments
Table 100. Shanghai United Cell Biotechnology Basic Information, Oral Live Cholera Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 101. Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Product Portfolios and Specifications
Table 102. Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Shanghai United Cell Biotechnology Main Business
Table 104. Shanghai United Cell Biotechnology Latest Developments
Table 105. Vabiotech Basic Information, Oral Live Cholera Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 106. Vabiotech Oral Live Cholera Vaccines Product Portfolios and Specifications
Table 107. Vabiotech Oral Live Cholera Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Vabiotech Main Business
Table 109. Vabiotech Latest Developments
LIST OF FIGURES
Figure 1. Picture of Oral Live Cholera Vaccines
Figure 2. Oral Live Cholera Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral Live Cholera Vaccines Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Oral Live Cholera Vaccines Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Oral Live Cholera Vaccines Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Euvichol- Plus
Figure 10. Product Picture of DUKORAL
Figure 11. Product Picture of Shanchol
Figure 12. Product Picture of Others
Figure 13. Global Oral Live Cholera Vaccines Sales Market Share by Type in 2023
Figure 14. Global Oral Live Cholera Vaccines Revenue Market Share by Type (2019-2024)
Figure 15. Oral Live Cholera Vaccines Consumed in Prevention
Figure 16. Global Oral Live Cholera Vaccines Market: Prevention (2019-2024) & (K Units)
Figure 17. Oral Live Cholera Vaccines Consumed in Emergency Response
Figure 18. Global Oral Live Cholera Vaccines Market: Emergency Response (2019-2024) & (K Units)
Figure 19. Global Oral Live Cholera Vaccines Sales Market Share by Application (2023)
Figure 20. Global Oral Live Cholera Vaccines Revenue Market Share by Application in 2023
Figure 21. Oral Live Cholera Vaccines Sales Market by Company in 2023 (K Units)
Figure 22. Global Oral Live Cholera Vaccines Sales Market Share by Company in 2023
Figure 23. Oral Live Cholera Vaccines Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Oral Live Cholera Vaccines Revenue Market Share by Company in 2023
Figure 25. Global Oral Live Cholera Vaccines Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Oral Live Cholera Vaccines Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Oral Live Cholera Vaccines Sales 2019-2024 (K Units)
Figure 28. Americas Oral Live Cholera Vaccines Revenue 2019-2024 ($ Millions)
Figure 29. APAC Oral Live Cholera Vaccines Sales 2019-2024 (K Units)
Figure 30. APAC Oral Live Cholera Vaccines Revenue 2019-2024 ($ Millions)
Figure 31. Europe Oral Live Cholera Vaccines Sales 2019-2024 (K Units)
Figure 32. Europe Oral Live Cholera Vaccines Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Oral Live Cholera Vaccines Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Oral Live Cholera Vaccines Revenue 2019-2024 ($ Millions)
Figure 35. Americas Oral Live Cholera Vaccines Sales Market Share by Country in 2023
Figure 36. Americas Oral Live Cholera Vaccines Revenue Market Share by Country in 2023
Figure 37. Americas Oral Live Cholera Vaccines Sales Market Share by Type (2019-2024)
Figure 38. Americas Oral Live Cholera Vaccines Sales Market Share by Application (2019-2024)
Figure 39. United States Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Oral Live Cholera Vaccines Sales Market Share by Region in 2023
Figure 44. APAC Oral Live Cholera Vaccines Revenue Market Share by Regions in 2023
Figure 45. APAC Oral Live Cholera Vaccines Sales Market Share by Type (2019-2024)
Figure 46. APAC Oral Live Cholera Vaccines Sales Market Share by Application (2019-2024)
Figure 47. China Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Oral Live Cholera Vaccines Sales Market Share by Country in 2023
Figure 55. Europe Oral Live Cholera Vaccines Revenue Market Share by Country in 2023
Figure 56. Europe Oral Live Cholera Vaccines Sales Market Share by Type (2019-2024)
Figure 57. Europe Oral Live Cholera Vaccines Sales Market Share by Application (2019-2024)
Figure 58. Germany Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Oral Live Cholera Vaccines Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Oral Live Cholera Vaccines Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Oral Live Cholera Vaccines Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Oral Live Cholera Vaccines Sales Market Share by Application (2019-2024)
Figure 67. Egypt Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Oral Live Cholera Vaccines in 2023
Figure 73. Manufacturing Process Analysis of Oral Live Cholera Vaccines
Figure 74. Industry Chain Structure of Oral Live Cholera Vaccines
Figure 75. Channels of Distribution
Figure 76. Global Oral Live Cholera Vaccines Sales Market Forecast by Region (2025-2030)
Figure 77. Global Oral Live Cholera Vaccines Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Oral Live Cholera Vaccines Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Oral Live Cholera Vaccines Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Oral Live Cholera Vaccines Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Oral Live Cholera Vaccines Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Oral Live Cholera Vaccines
Figure 2. Oral Live Cholera Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral Live Cholera Vaccines Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Oral Live Cholera Vaccines Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Oral Live Cholera Vaccines Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Euvichol- Plus
Figure 10. Product Picture of DUKORAL
Figure 11. Product Picture of Shanchol
Figure 12. Product Picture of Others
Figure 13. Global Oral Live Cholera Vaccines Sales Market Share by Type in 2023
Figure 14. Global Oral Live Cholera Vaccines Revenue Market Share by Type (2019-2024)
Figure 15. Oral Live Cholera Vaccines Consumed in Prevention
Figure 16. Global Oral Live Cholera Vaccines Market: Prevention (2019-2024) & (K Units)
Figure 17. Oral Live Cholera Vaccines Consumed in Emergency Response
Figure 18. Global Oral Live Cholera Vaccines Market: Emergency Response (2019-2024) & (K Units)
Figure 19. Global Oral Live Cholera Vaccines Sales Market Share by Application (2023)
Figure 20. Global Oral Live Cholera Vaccines Revenue Market Share by Application in 2023
Figure 21. Oral Live Cholera Vaccines Sales Market by Company in 2023 (K Units)
Figure 22. Global Oral Live Cholera Vaccines Sales Market Share by Company in 2023
Figure 23. Oral Live Cholera Vaccines Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Oral Live Cholera Vaccines Revenue Market Share by Company in 2023
Figure 25. Global Oral Live Cholera Vaccines Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Oral Live Cholera Vaccines Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Oral Live Cholera Vaccines Sales 2019-2024 (K Units)
Figure 28. Americas Oral Live Cholera Vaccines Revenue 2019-2024 ($ Millions)
Figure 29. APAC Oral Live Cholera Vaccines Sales 2019-2024 (K Units)
Figure 30. APAC Oral Live Cholera Vaccines Revenue 2019-2024 ($ Millions)
Figure 31. Europe Oral Live Cholera Vaccines Sales 2019-2024 (K Units)
Figure 32. Europe Oral Live Cholera Vaccines Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Oral Live Cholera Vaccines Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Oral Live Cholera Vaccines Revenue 2019-2024 ($ Millions)
Figure 35. Americas Oral Live Cholera Vaccines Sales Market Share by Country in 2023
Figure 36. Americas Oral Live Cholera Vaccines Revenue Market Share by Country in 2023
Figure 37. Americas Oral Live Cholera Vaccines Sales Market Share by Type (2019-2024)
Figure 38. Americas Oral Live Cholera Vaccines Sales Market Share by Application (2019-2024)
Figure 39. United States Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Oral Live Cholera Vaccines Sales Market Share by Region in 2023
Figure 44. APAC Oral Live Cholera Vaccines Revenue Market Share by Regions in 2023
Figure 45. APAC Oral Live Cholera Vaccines Sales Market Share by Type (2019-2024)
Figure 46. APAC Oral Live Cholera Vaccines Sales Market Share by Application (2019-2024)
Figure 47. China Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Oral Live Cholera Vaccines Sales Market Share by Country in 2023
Figure 55. Europe Oral Live Cholera Vaccines Revenue Market Share by Country in 2023
Figure 56. Europe Oral Live Cholera Vaccines Sales Market Share by Type (2019-2024)
Figure 57. Europe Oral Live Cholera Vaccines Sales Market Share by Application (2019-2024)
Figure 58. Germany Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Oral Live Cholera Vaccines Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Oral Live Cholera Vaccines Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Oral Live Cholera Vaccines Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Oral Live Cholera Vaccines Sales Market Share by Application (2019-2024)
Figure 67. Egypt Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Oral Live Cholera Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Oral Live Cholera Vaccines in 2023
Figure 73. Manufacturing Process Analysis of Oral Live Cholera Vaccines
Figure 74. Industry Chain Structure of Oral Live Cholera Vaccines
Figure 75. Channels of Distribution
Figure 76. Global Oral Live Cholera Vaccines Sales Market Forecast by Region (2025-2030)
Figure 77. Global Oral Live Cholera Vaccines Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Oral Live Cholera Vaccines Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Oral Live Cholera Vaccines Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Oral Live Cholera Vaccines Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Oral Live Cholera Vaccines Revenue Market Share Forecast by Application (2025-2030)
More Publications
Global Medical Solid Waste Treatment Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
December 2024
113 pages
Global Natural Appetite Suppressants Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
March 2024
124 pages
Global Surgical Basin Stands Market Growth 2024-2030
US$ 3,660.00
September 2024
153 pages
Global Handheld Surgical Instrument Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
January 2025
119 pages
Global Cardiac Stress Test Equipment Market Growth 2023-2029
US$ 3,660.00
February 2023
105 pages
